Borosil Scientific Investor Presentation: Key Takeaways
Q2FY27 consolidated sales ₹115.0 Cr (+7.6%), EBITDA ₹11.0 Cr (+29.4%), PAT ₹5.3 Cr (+86.3%). Standalone PAT fell 16.9% on input costs.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Q2FY27 consolidated sales ₹115.0 Cr (+7.6%), EBITDA ₹11.0 Cr (+29.4%), PAT ₹5.3 Cr (+86.3%). Standalone PAT fell 16.9% on input costs.
Borosil Scientific approved a Rs.70 Crore, 20 MT per day glass tubing furnace. Commercial production is expected by March 2028.
Borosil Scientific Ltd reported revenue from operations of ₹115 Cr (+7.6% YoY) and net profit of ₹5.3 Cr (+89.3% YoY) for Q2 FY27.
Borosil Scientific Limited will hold a board meeting on October 28, 2026, to consider and approve its unaudited financial results for the quarter ended September 30, 2026.
Borosil Scientific Ltd submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026. This is a routine periodic regulatory disclosure.